Kannalife Secures Funding of $1.49 Million from The Michael J. Fox Foundation for Parkinson’s Research

2 weeks ago

Funding of $1.49 million USD to support the development of KLS-13019 targeting neuroinflammation and mitochondrial dysfunction Kannalife has developed a…

Industry Leader John Maraganore, Ph.D., Joins Cybrexa Therapeutics as Strategic Advisor

2 weeks ago

NEW HAVEN, Conn., June 25, 2024 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a clinical-stage oncology biotechnology company developing a novel class…

Tevogen Bio Announces Publication of Positive Phase I Clinical Trial Results for TVGN 489 in Blood Advances

2 weeks ago

WARREN, N.J., June 25, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage…

Data Supporting Nanox.AI Cardiac Solution to Be Presented at 19th Annual Meeting of the Society of Cardiovascular Computed Tomography

2 weeks ago

PETACH TIKVA, Israel, June 25, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative…

EY Announces Eric Reimer of Healthmap Solutions as an Entrepreneur Of The Year® 2024 Florida Award Winner

2 weeks ago

Celebrating the bold leaders who disrupt markets, revolutionize industries, and transform livesTAMPA, Fla., June 25, 2024 (GLOBE NEWSWIRE) -- Ernst…

Monopar Announces MNPR-101-RIT Abstract Accepted as a Top-Rated Oral Presentation at EANM’24

2 weeks ago

WILMETTE, Ill., June 25, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharma company focused on developing…

Tonix Pharmaceuticals Presents Vaccine Platform Data in Keynote Talk at the Vaccine Congress 2024

2 weeks ago

Tonix’s live virus vaccine TNX-801 is designed to provide long-term protection from mpox and smallpox with one dose TNX-801 vaccination…

New Study From Inovalon and Genentech Finds Racial Disparities In Emergency Department Visits For Liver Cancer Care

2 weeks ago

Research Reveals How Social Drivers of Health Influence Higher Rates of Emergency Department Utilization for Black and Hispanic Hepatocellular Carcinoma…

GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease

2 weeks ago

Results from commercial sales of predictive testing across the US and Australia establish clear advantages of geneType Risk Assessment Tests…

electroCore Announces the Commercial Launch of TAC-STIM™

2 weeks ago

Upgraded TAC-STIM enhances Energy, Focus and ReadinessROCKAWAY, N.J., June 25, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage…